Carregant...
Vascular endothelial growth factor trap-eye and trap technology: Aflibercept from bench to bedside
Anti-vascular endothelial growth factor (VEGF) currently used to treat eye diseases have included monoclonal antibodies, antibody fragments, and an aptamer. A different method of achieving VEGF blockade in retinal diseases includes the concept of a cytokine trap. Cytokine traps technology are being...
Guardat en:
| Publicat a: | Oman J Ophthalmol |
|---|---|
| Autor principal: | |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Medknow Publications & Media Pvt Ltd
2014
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4220395/ https://ncbi.nlm.nih.gov/pubmed/25378873 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/0974-620X.142591 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|